Clenbuterol by Dragon Pharma

Dragon Pharma Original Formula

Clenbuterol

Clenbuterol40 mcg/tab
Class Beta-2 Agonist
Half-Life ~35–40 hours
Primary Action Thermogenic / Lipolytic
Hormonal Effect None (HPG)
Pack 100 tabs
Form Oral Tablet
Availability: In Stock
$44.00
Quantity
Shipping
Wishlist

Clenbuterol 40mcg by Dragon Pharma

Clenbuterol is Dragon Pharma's formulation of Clenbuterol Hydrochloride at 40mcg per tablet — a beta-2 adrenergic agonist originally developed as a bronchodilator for asthma treatment, widely used in bodybuilding for its thermogenic and anti-catabolic properties. Supplied in a 100-tablet pack, Clenbuterol requires specific cycling protocols due to beta-2 receptor downregulation — a physiological mechanism that competitors consistently fail to explain properly.

Also searched as: Clenbuterol 40mcg, Clen tabs, Clenbuterol HCl, Clenbuterol Dragon Pharma.

How Clenbuterol Works — The Full Mechanism

Clenbuterol acts primarily as a beta-2 adrenergic receptor (β2-AR) agonist — but its effects extend across several biological systems:

  • Thermogenesis: Beta-2 receptor activation in adipose tissue increases uncoupling protein expression and mitochondrial heat production — raising basal metabolic rate (BMR) by an estimated 5-10% above baseline in human studies. This translates to approximately 100-200 additional calories burned per day at therapeutic doses
  • Lipolysis: β2-AR activation in adipocytes activates hormone-sensitive lipase (HSL) and increases intracellular cAMP, stimulating the breakdown of stored triglycerides into free fatty acids for oxidation
  • Anti-catabolism: Less commonly explained — Clenbuterol also activates beta-2 receptors in skeletal muscle, increasing protein synthesis and reducing protein breakdown through mTOR pathway stimulation. This anti-catabolic effect is clinically documented and is why Clenbuterol is used in muscle-wasting conditions and why it's valued during caloric deficits where lean tissue preservation is a priority
  • Bronchodilation: The original clinical indication — relaxation of bronchial smooth muscle via beta-2 receptor activation

Why 2-Week On/Off Cycling Is Mechanistically Required

This is the most important and most poorly explained aspect of Clenbuterol use in competitor content:

  • Beta-2 receptors downregulate (decrease in number and sensitivity) in response to continuous agonist stimulation — this is a universal feature of G-protein coupled receptor biology, not specific to Clenbuterol
  • With continuous Clenbuterol use, beta-2 receptor density decreases by approximately 50% within 2 weeks at consistent doses — the thermogenic and lipolytic effects diminish proportionally
  • Clenbuterol's long half-life of ~35-40 hours is critical here: unlike short-acting beta-2 agonists where the receptor can partially recover between doses, Clenbuterol's sustained presence means receptors are continuously occupied, accelerating downregulation
  • The 2-week off period allows beta-2 receptor density to upregulate back toward baseline — receptors are resynthesised over this period, restoring sensitivity for the next on-cycle
  • Attempting to counteract downregulation by increasing dose provides diminishing returns and increases side effects without proportionally restoring efficacy — the 2-week break remains superior to dose escalation for preserving long-term thermogenic response

Why Clenbuterol Causes Muscle Cramps — The Taurine Mechanism

One of the most consistently asked questions about Clenbuterol and one of the least well-explained:

  • Clenbuterol significantly increases taurine excretion via the kidneys — taurine is lost in urine at a rate that often exceeds dietary intake during Clenbuterol use
  • Taurine is required for proper calcium handling in skeletal muscle — specifically, it is involved in the regulation of sarcoplasmic reticulum calcium release and re-uptake
  • Taurine depletion impairs this calcium regulation, causing muscle cells to have dysregulated calcium cycling — the result is the involuntary, painful muscle contractions (cramps) characteristic of Clenbuterol use
  • Practical solution: taurine supplementation at 3-5g/day during Clenbuterol use effectively prevents or significantly reduces cramping in most users — this is not a general electrolyte problem but a specific taurine depletion mechanism

Effects and Benefits

  • Increased basal metabolic rate — estimated 5-10% above baseline (approximately 100-200 kcal/day) at therapeutic doses
  • Enhanced lipolysis via beta-2 receptor-mediated cAMP/HSL activation in adipose tissue
  • Anti-catabolic effect in skeletal muscle — valuable during caloric deficits alongside AAS cycles
  • Mild appetite suppression reported by some users due to sympathomimetic activity
  • No suppression of natural testosterone — does not require Post Cycle Therapy

Dosage and Administration

Week Daily Dose (Men) Daily Dose (Women) Tablets (40mcg)
Week 1 40–60 mcg 20–40 mcg 1–1.5 tabs (men) / 0.5–1 tab (women)
Week 2 80–120 mcg 40–60 mcg 2–3 tabs (men) / 1–1.5 tabs (women)
Weeks 3–4 OFF OFF
Repeat cycle Resume at Week 1 dose Resume at Week 1 dose

Maximum dose: 120-140mcg/day for men; 80-100mcg/day for women — above these thresholds, cardiac side effects become significant without proportional fat loss benefit. Morning dosing is preferred to minimise sleep disruption from sympathomimetic stimulation. Taurine 3-5g/day should be taken throughout to prevent cramping.

Side Effects

  • Tremors (hand shaking) — most commonly reported, directly related to beta-2 receptor stimulation in skeletal muscle; dose-dependent and diminishes as receptor sensitivity adapts over days
  • Elevated heart rate and palpitations — sympathomimetic cardiovascular effects; avoid in individuals with cardiac conditions; monitor resting heart rate
  • Muscle cramps — taurine depletion mechanism (see above); prevented by taurine supplementation
  • Insomnia — sympathomimetic stimulation; morning dosing minimises this
  • Sweating and body heat — direct consequence of thermogenic mechanism; expected and confirms activity
  • No suppression of natural testosterone — PCT not required

Clenbuterol vs Other Fat Loss Compounds in the Dragon Pharma Range

Compound Mechanism Primary Advantage Best For
Clenbuterol Beta-2 agonist — thermogenic + anti-catabolic Anti-catabolic preservation of lean mass Cutting while maintaining muscle
T3 (Liothyronine) Thyroid hormone — metabolic acceleration Most powerful metabolic rate increase Aggressive fat loss, requires AAS protection
Tirzepatide GLP-1/GIP agonist — appetite suppression Greatest total weight loss — Phase III data Significant body weight reduction
AOD-9604 GH fragment — targeted lipolysis No IGF-1 elevation, specific fat metabolism Fat metabolism without anabolic effects

Building a Cutting Protocol Around Clenbuterol

  • Testosterone Propionate or Enantat 250 as the AAS base to protect lean mass alongside Clenbuterol during a caloric deficit
  • Anavar for a lean mass-preserving oral addition alongside Clenbuterol
  • Winstrol 10 for hardness and vascularity alongside thermogenic fat loss

"Clenbuterol is formulated at the standard 40mcg tablet strength that allows systematic titration from a single tablet to 2-3 tablets daily across the two-week on-cycle window, with each increment easily measurable."

Storage and Handling

Store Clenbuterol at room temperature, away from direct sunlight and moisture. Keep the original packaging sealed until use to maintain tablet potency.

Please log in to write review.

Beta-2 adrenergic receptors downregulate — decrease in number and sensitivity — with continuous agonist stimulation. With Clenbuterol's long ~35-40 hour half-life, receptors are continuously occupied, accelerating this downregulation. Studies suggest beta-2 receptor density can decrease by approximately 50% within 2 weeks of consistent use. The 2-week off period allows receptor density to recover, restoring thermogenic response for the next cycle.

Clenbuterol significantly increases taurine excretion in the urine, depleting taurine faster than diet replaces it. Taurine is required for proper calcium regulation in skeletal muscle — specifically controlling calcium release and uptake from the sarcoplasmic reticulum. Taurine depletion impairs this calcium handling, causing the involuntary muscle cramps characteristic of Clenbuterol use. Supplementing 3-5g of taurine daily during Clenbuterol use is the specific, mechanistic solution — not general electrolyte supplementation.

No — Clenbuterol has a documented anti-catabolic effect in skeletal muscle via beta-2 receptor activation and mTOR pathway stimulation. This actually reduces muscle protein breakdown during caloric deficits, which is one reason it's valued during cutting phases alongside AAS cycles. Its anti-catabolic properties are clinically recognised from its use in muscle-wasting conditions.

Human studies on beta-2 agonists suggest a basal metabolic rate increase of approximately 5-10% above baseline at therapeutic doses. For most users, this translates to approximately 100-200 additional calories burned per day — meaningful but not dramatic on its own, which is why Clenbuterol is most effective as part of a caloric deficit rather than as a standalone fat loss tool.

Tremors are a direct consequence of beta-2 receptor stimulation in skeletal muscle — the same receptor activation that produces thermogenic and anti-catabolic effects also causes the mild involuntary contractions experienced as hand shaking. This effect typically diminishes over the first few days as receptor sensitivity partially adapts, and is dose-dependent.

Yes — Clenbuterol does not affect testosterone or the HPG axis and does not require PCT. However, during significant caloric deficits, lean mass loss becomes a concern. Clenbuterol's anti-catabolic effects provide some protection, but pairing with a testosterone base or lean-friendly AAS like Anavar provides significantly better lean mass preservation during aggressive fat loss phases.

Related Products